Business Wire

Experience the World of Interconnected Security on IDEMIA’s Booth at Milipol Paris (november 19-22, 2019)

Share

Today, more than ever before, new digital and biometric technologies represent the future of public security to provide trusted and reliable security solutions based on identity, and to maintain at the same time efficiency and convenience that ease citizens’ lives.

At Milipol Paris, IDEMIA will showcase its cutting-edge technologies in three fields so that visitors can experience the whole future of security.

  • Securing major events

Thanks to its 40 years of strong relationships with the world’s leading law enforcement agencies and governments, IDEMIA has developed an in-depth understanding of the processes and procedures involved to ensure security at major events. The company not only provides the most innovative, biometric technologies – it also ensures interoperability of systems for a smooth and efficient running of events.
IDEMIA’s innovative and intelligent systems use highly accurate algorithms integrated in its video and intelligence analytics to help secure major event, critical buildings, and infrastructures such as malls, hospitals and airports. IDEMIA’s range of solutions helps operators prevent offences by identifying persons or objects of interest and investigate faster once an event occurs.

  • Securing borders

Travelers can cross a country’s borders by sea, air or road, and governments need to ensure that each border is secure. Government agencies face conflicting objectives: securing borders while facilitating an increasing flow of travelers crossing them. IDEMIA’s interoperable and fully scalable suite of products and services helps governments create a border control solution best adapted to their needs. Combining API/PNR information with a traveler’s multi-biometrics (fingerprint, face and iris) makes the border crossing process almost foolproof. The company has designed a comprehensive traveler data collection and risk assessment solution to improve the border management process, in compliance with regulations and respect of privacy.

  • Securing the community

Crime prevention forms the very basis for ensuring safe citizens and cities. In times of possible insecurity, assessing the threat level of individuals is crucial in order to prevent attacks. Law enforcement agents need tools that can speed up the decision-making process on whether to act or not. An important step to overcome this challenge of time and resources is to provide officers with advanced mobile tools and equipment that will help them conduct identification on the beat. IDEMIA has developed a mobile app that uses the camera of a mobile phone to identify a suspect by matching the fingerprints or the face of the suspect automatically against a central database. Adding more biometric solutions to smartphones will save police officers valuable time and effort.

Biometric technologies are a key contributor to resolving today's security challenges and improving the way we want to live in our cities safely. It indeed provides the ideal match between the high accuracy needed by public authorities and the level of convenience required by citizens living in a digital world. Through highly secure, non-intrusive solutions, we are helping authorities around the world create safer places to live.” said Philippe BARREAU, Executive Vice President for Public Security & Identity activities at IDEMIA.

Take a tour of our Experience, Booth #D168 - Hall 5
to experience the future of safe cities by IDEMIA.
Our experts look forward to meeting you!

IDEMIA’s innovations on the booth:

  • IDEMIA Traveler Analytics Suite: smart analytics for your border management strategies.
  • Video and Intelligence Analytics: our offer supports security officers in identifying and tracking persons or objects of interest
  • Intuitive tactical control & command software integrating video analytics platform allowing operators to react on an alert immediately
  • Mobile Biometric Check, to perform in-the-field biometric checks with your smartphone
  • MBIS, the innovative Automated Biometric Identification System to meet the growing need for real-time identification of suspects and criminals,
  • MESTAfusion, to detect and enforce different types of traffic violations to improve safety and respectful behavior on the roads
  • MESTAcontrol, the Intelligent Transportation System back office solution to gather and process traffic management data for safer roads

About IDEMIA

IDEMIA, the global leader in Augmented Identity, provides a trusted environment enabling citizens and consumers alike to perform their daily critical activities (such as pay, connect and travel), in the physical as well as digital space.
Securing our identity has become mission critical in the world we live in today. By standing for Augmented Identity, an identity that ensures privacy and trust and guarantees secure, authenticated and verifiable transactions, we reinvent the way we think, produce, use and protect one of our greatest assets – our identity – whether for individuals or for objects, whenever and wherever security matters. We provide Augmented Identity for international clients from Financial, Telecom, Identity, Public Security and IoT sectors.
With 13,000 employees around the world, IDEMIA serves clients in 180 countries.

For more information, visit www.idemia.com / Follow @IDEMIAGroup on Twitter

Contact information

Press
Hanna SEBBAH - idemia@havas.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Avanti Acquisition Corp. Announces Launch of $500,000,000 Initial Public Offering1.10.2020 10:00:00 EESTPress release

Avanti Acquisition Corp. (the “Company”), a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, today announced the commencement of its initial public offering of 50,000,000 units at a price of $10.00 per unit. The Company is sponsored by Avanti Acquisition SCSp, an affiliate of NNS Group, the private family office of Nassef Sawiris and Sienna Capital, a subsidiary of Groupe Bruxelles Lambert. The Company intends to be sector agnostic and to focus on European family owned or founder led businesses with a US nexus. The units are expected to be listed on the New York Stock Exchange (the “NYSE”) and trade under the ticker symbol “AVAN.U”. Each unit consists of one share of Class A common stock and one-half of one redeemable warrant. Each whole warrant may be exercised for one share of Class A common stock at a price of $11.50 per share. Only

Castles Technology Announces the Acquisition of Spire Payments1.10.2020 08:59:00 EESTPress release

Castles Technology, one of the top global payment solutions providers which offers services to more than 50 countries around the globe, today announced completion of the acquisition of the business and assets of Spire Payments, the leading European based EFTPOS terminal solutions provider. With the acquisition of the business and assets of Spire Payments, Castles Technology is now even better positioned to deliver market-leading payment solutions that simplify and enhance merchants’ businesses, from in-store acceptance services to value-added solutions. Jean-Philippe Niedergang, Group CCO Castles Technology, says: “I am delighted to welcome Spire Payments’ customers and new colleagues to the Castles Technology family. This acquisition represents an important strategic move for the future of our businesses, as we continue to evolve and innovate to provide merchants acquirers with future-forward payments solutions.” “This acquisition delivers a perfect match between the two companies, wi

BIOCORP Announces Partnership with AARDEX Group to Extend Smart Solutions for Precision Medication Adherence1.10.2020 08:30:00 EESTPress release

Regulatory News: BIOCORP (Paris:ALCOR) (FR0012788065 - ALCOR / Eligible PEA PME), a French company specialized in the design, development and manufacture of innovative medical devices, today announced an alliance with Belgium-based AARDEX Group, the world leader in medication adherence solutions. This alliance is to combine BIOCORP’s connected add-on solutions for drug delivery devices with AARDEX’s proprietary Medication Event Monitoring System (MEMS®) and offer a comprehensive solution to patients and healthcare providers to effectively measure and manage medication adherence. The financial terms of the agreement have not been disclosed, however the first initiative will be to integrate BIOCORP’s Injay connected solution for Pre-filled syringes (PFS) to AARDEX’s MEMS Adherence Software (MEMS AS®), to target medicines delivered by PFS with potential applications in the field of Rheumatoid Arthritis, Multiple Sclerosis, Ophthalmology, Psoriasis or Cardiovascular diseases. The roadmap a

JEOL Strengthens European Business in the Medical Equipment Segment1.10.2020 03:30:00 EESTPress release

JEOL Ltd. (TOKYO:6951) (President & COO Izumi Oi) has opened a new facility in JEOL (EUROPE) B.V. (Zaventem, Belgium) on October 1, 2020, aiming to strengthen the Medical Equipment business in Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200930006021/en/ Demo site JEOL (EUROPE) B.V. (Photo: Business Wire) This foundation, with three instruments in operation, not only offers customers the possibility of practical demonstrations and intensive service / application training, but also enables high-quality service and fast logistics from the dedicated warehouse. This new approach is based on a long-term plan that whilst keeping pace with a high standard and matured medical environment in Europe, we will also cover emerging regions such as the Middle East, Eastern Europe and Russia, where the expected growth in economy and population can lead to a steady demand for medical infrastructure. We will continue to promote over

International AI Art Competition Enters Final Round30.9.2020 19:16:00 EESTPress release

Ten finalists have been announced for AI Artathon, the first ever international AI Art competition held in Saudi Arabia. The finalists were revealed during a livestream event to showcase artworks created by the competitors using artificial intelligence tools and techniques. The three winning teams will be announced at the Global AI Summit on 22nd October, where they will share a prize of US$133,000. The AI Artathon is an initiative of the Global AI Summit, to highlight the creative potential of humans and machines working together to create innovative artworks. Twenty teams made up of artists, graphic designers, AI experts and programmers, competed in this stage of the competition, after qualifying during a hackathon held in Riyadh in January. Over 2,000 people from over 50 countries applied to participate in the hackathon, with 300 selected for the three-day event, where teams were formed to develop initial AI art concepts. Twenty teams were selected to take part in a bootcamp, where

VALBIOTIS Publishes Its 2020 Half-Year Results and Provides an Update on Its Global Strategic Partnership with Nestlé Health Science, its strong Financial Visibility and the Promising Advances in Its Pipeline30.9.2020 18:40:00 EESTPress release

Regulatory News: VALBIOTIS (Paris:ALVAL) (FR0013254851 – ALVAL / eligible for the PEA/SME), a Research & Development company committed to scientific innovation for preventing and combating metabolic diseases, announces its results for the first half of 2020 and provides an update on developments since the beginning of the year. Sébastien PELTIER, CEO of VALBIOTIS, commented: "Events in the first half of 2020 have transformed our outlook and helped further boost our international recognition. With the signature of the development and marketing partnership for TOTUM-63 and the launch of the final clinical phase for this Nutrition Healthcare product, entirely financed by Nestlé Health Science, we have demonstrated the soundness of our development model. We are now moving confidently towards marketing and claim submission for TOTUM-63 and, thanks to a solid financial position, we are also working to apply this same model to the rest of our Nutrition Healthcare portfolio. At the head of the

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom